Oral Antifungal Treatment for Thrush

Treatment Recommendations

The Infectious Diseases Society of America recommends oral fluconazole 100-200 mg daily for 7-14 days as the first-line treatment for mild oropharyngeal thrush, offering superior efficacy and compliance compared to topical alternatives 1, 2
For moderate to severe disease, oral fluconazole 100-200 mg daily for 7-14 days is strongly recommended, representing a higher strength of recommendation than topical agents 1, 2
The American College of Physicians and the Infectious Diseases Society of America suggest that fluconazole demonstrates superior clinical cure rates, lower colonization rates, and significantly better patient compliance compared to clotrimazole troches 1, 2
For fluconazole-refractory disease, first-line alternatives include itraconazole solution 200 mg once daily for up to 28 days and posaconazole suspension 400 mg twice daily for 3 days, then 400 mg daily for up to 28 days 1, 2
Second-line alternatives for fluconazole-refractory disease include voriconazole 200 mg twice daily and amphotericin B deoxycholate oral suspension 100 mg/mL 4 times daily 1, 2

For chronic suppressive therapy, fluconazole 100 mg three times weekly is recommended only for patients with recurrent infections where suppression is necessary 1, 2
In HIV-infected patients, antiretroviral therapy is strongly recommended to reduce recurrence incidence, and the same treatment regimens apply, but recurrence risk is higher without immune reconstitution 1, 2
For denture-related candidiasis, disinfection of the denture in addition to antifungal therapy is required for successful treatment 1

Topical agents should not be used for moderate-to-severe disease, as oral fluconazole is superior and has strong evidence 1, 2
Ineffective therapy should not be continued, and alternative agents should be considered for refractory disease 1, 2
Underlying causes, such as denture hygiene and immune function, should not be overlooked 1